Ohio State Navbar

Directory

Eric Kraut, MD


Staff photo

320 W 10th Ave
Columbus, OH 43210

Phone: (614) 293-3161

Email: kraut.2@osu.edu

 

Current OSU Appointments

Professor, Hematology

Physician, FGP-Hematology

 

Biographical

Eric H. Kraut, MD, is Professor of Internal Medicine, Division of Hematology, at Arthur G. James Cancer Hospital & Richard Solove Research Institute at The Ohio State University in Columbus, where he also directs the Benign Hematology Program, the Sickle Cell Program, and the Thrombosis and Hemophilia Center.



Dr. Kraut received his medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania. He completed an internship and residency at University of Pittsburgh in Pennsylvania and a fellowship at The Ohio State University, Division of Hematology and Oncology. He is board certificated in internal medicine, hematology, and oncology.



Dr. Kraut has authored or co-authored over 98 journals, 10 book chapters and monographs, and 92 abstracts, in addition to frequently lecturing. He is a 2012 Biographical Candidate in the “Who's Who Among Executives and Professionals, Honors Edition" Registry.



Dr. Kraut holds professional membership with the American Society of Hematology and American Society of Clinical Oncology. He also serves on multiple committees, such as the Finance Committee Department of Medicine, Adult Sickle Cell Steering Committee, ASH Teaching Cases Subcommittee, and Anticoagulation Therapy Workgroup. He is a member of the NCCN Cancer- and Chemotherapy-Induced Anemia Panel.

Academic Advising

2012 - present Korkor Sackey The Ohio State University.
2011 Scha'Chia Murphy The Ohio State University.
 

Books

Eric Kraut, Aledort LM, Arkin S, Stine KC, Wong W-Y.. Surgical Procedures in Patients With Inhibitors To Factor VIII: A Case Series.. Columbus, OH: Haemophilia, January 2006.

 

Certifications

1975 - present Medical License: State Medical Board of Ohio
1975 - present Board Certification: American Board of Internal Medicine
1977 - present Board Certification: American Board of Internal Medicine
1978 - present Board Certification: American Board of Internal Medicine
1973 - 1975 Board Certification: Temple University
 

Chapters in Books

Dr. Eric H. Kraut. "Diseases of the Spleen." In Current Diagnosis 5. Edited by LoBuglio, AF. 519-521. Philadelphia: WB Saunders: HF Conn and RB Conn eds, January 1977.

Dr. Eric H. Kraut and AF LoBuglio ed. "Drug Regimens in the Treatment of Cancer of the Lung, Cancer of the Skin, and Cancer of the Endocrine System." In Current Chemotherapy Manual, (Booklet). -. Columbus: The Ohio State University Cancer Center: January 1977.

Dr. Eric Harvey Kraut. "Complications of Cancer and Cancer Therapy." In Internal Medicine, Third edition, Stein JH ed,. -. Columbus, OH: In Internal Medicine, Third edition, Stein JH ed, (Boston: Little, Brown and Company, January 1989.

Dr. Eric Harvey Kraut. "Lymphoma’s, Otolaryngology - Head and Neck Surgery." In Mosby Year Book, Inc. -. January 1998.

Dr. Eric Harvey Kraut. "Lymphoma’s, Otolaryngology - Head and Neck Surgery." In Hairy Cell Leukemia. -. Mosby Year Book, Inc, January 1998.

Dr. Eric Harvey Kraut and Grever MR, Doan CA. "Pentostatin in the Treatment of Hairy Cell Leukemia." In Best Practice & Research Clinical Haematology. 16(1):91-9. January 2003.

Dr. Eric Harvey Kraut. "Clinical Manifestations Complications and Infections of Hairy Cell Leukemia." In Best Practice & Research Clinical Haematology. 16(1):33-40. January 2003.

Dr. Eric Harvey Kraut. "Hairy Cell Leukemia - Definitions of Remission, Prognosis and." In McGraw-Hill , Medical Publishing Division. -. January 2005.

 

Degrees

1968 B.A., Franklin and Marshall College

1972 M.D., Temple University

 

Editorial Activities

1994 - 1995 American Journal of Hematology
1998 - 1999 Investigational New Drugs
2003 - 2004 American Journal of Hematology
2003 - 2007 BLOOD
2005 Investigational New Drugs
2005 - 2008 Hematolgica
2006 BLOOD
2006 - 2007 Annals of Internal Medicine
2007 - present Haematologica
2007 Blood
2008 - present Haematologica
2008 - present BLOOD
2009 - present Cancer Chemotherapy
2009 - present Leukemia and Lymphoma
2009 - present Pharmacology
 

Honors

1970 Junior, Fellow. American Cancer Society.
1976 - 1977 Fellow-Ohio. American Cancer Society.
1978 - 1981 Junior Faculty Fellow. American Cancer Society.
1982 - 1983 Oustsanding Module, Med II. American Cancer Society.
2002 - 2003 Bertha Borouncle Teaching Award. Department of Hematology and Oncology.
2007 America's Best Doctors. U.S. News & World Report.
2008 Nominated for the 2008 Earl N. Metz Distinguished Physician Award. The Ohio State University.
2009 Earl N. Metz Distinguished Physician Award. The Ohio State University.
2010 Biographical Candidate "Who's Who Among Executives and Professionals", "Honors Edition" Registry. Who's Who in America.
 

Journal Articles

Kraut EH and King GW. "Management of Hodgkin's Disease and Non-Hodgkin's Lymphoma." Med Opinion. no. 6. (January 1977.): 16-25.

Kraut EH, Metz EN and Sagone AL Jr. "In Vitro Effects of Ascorbate on White Cell Metabolism and the Chemiluminescence Response.." J Reticuloendothel Soc. Vol. 27, no. 27. (January 1980.): 359-366.

Kraut EH and Sagone AL Jr. "Alternative Pathway of Complement in Multiple Myeloma." Am J Hematol. Vol. 11, no. 11. (January 1981.): 335-345.

Kraut EH and Sagone AL Jr. "The Effect of Oxidant Injury on the Lymphocyte Membrane and Functions." J Lab Clin Med. Vol. 98, no. 98. (January 1981.): 697-703.

Kraut EH, Segal M and Sagone AL Jr. "Evaluation of the Role of Oxygen Radicals in Polymorphonuclear Leukocyte Aggregation." Inflammation. Vol. 181, no. 6. (January 1982.): 161-167.

Brubaker, L, H; Briere, J; Laszlo, J; Kraut, E; Landaw, S, A; Peterson, P; Goldberg, J; Donovan, P. "Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only.." Archives of internal medicine. Vol. 142, no. 8. (January 1982.): 1533-7.

Fromkes,J,J; Thomas,F,B; Kraut,E,H. "ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY IN ASCITIC FLUID DURING SPONTANEOUS BACTERIAL PERITONITIS." JOURNAL OF CLINICAL GASTROENTEROLOGY. Vol. 4, no. 4. (January 1982.): 347-350.

Saiki, J, H; Baker, L, H; Stephens, R, L; Fabian, C, J; Kraut, E, H; Fletcher, W S. "Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.." Cancer treatment reports. Vol. 66, no. 8. (January 1982.): 1673-4.

Fromkes, J, J; Thomas, F, B; Kraut, E H. "Activation of the alternative complement pathway in ascitic fluid during spontaneous bacterial peritonitis.." Journal of clinical gastroenterology. Vol. 4, no. 4. (January 1982.): 347-50.

Segal, M, L; Fertel, R, H; Kraut, EH; Sagone, A L. "The role of reactive oxygen species in thromboxane b2 generation by polymorphonuclear leukocytes.." The Journal of laboratory and clinical medicine. Vol. 102, no. 5. (January 1983.): 788-94.

Tuomari, D, L; Olsen, R, G; Mathes, L, E; Kraut, EH. "Feline complement dependent binding in the Raji cell assay is insufficient for the quantitation of immune complexes.." Veterinary immunology and immunopathology. Vol. 5, no. 1. (January 1983.): 77-83.

Kraut EH, Tuomari D, Olsen R, Mathes L. "Raji Cell Complement Receptors are Incompatible with Feline Complement for Use in Complement Detection of Immune Complexes." J Vet Immunol Immunopath. Vol. 9, no. 15. (January 1983.): 77-83.

Kraut EH, Sagone AL Jr, Greenwald J, Bianchine J and Singh DJ. "Glucose: A Role as a Free Radical Scavenger in Biological Systems." J Lab Clin Med. Vol. 101, no. 101. (January 1983.): 97-104.

Golomb,H,M; Kraut,E,H; OVIATT,D,L; PRENDERGAST,E,J; Stein,R,S; SWEET,D,L. "ABSENCE OF PROLONGED BENEFIT OF INITIAL LEUKAPHERESIS THERAPY FOR HAIRY-CELL LEUKEMIA." AMERICAN JOURNAL OF HEMATOLOGY. Vol. 14, no. 1. (January 1983.): 49-56.

Kraut EH, Tuomari D, Olsen R and Singh V. "Detection of Circulating Immune Complexes by a Clq Protein During the Preneoplastic Stages of Feline Leukemia Virus Pathogenesis." J Vet Immunol Immunopath. Vol. 7, no. 17. (January 1984.): 227-238.

Kraut EH, Neidhart JA, Derocher D, Grever MR and Malspeis L. "Phase I Trial of Tiazine Triepoxide (Henkel's Compound, NSC-296934N)." Cancer Treat Rep. Vol. 1, no. 68. (January 1984.): 1115-1119.

Kraut EH, Hebert IA, Waxman FJ, Birmingham DJ, Van Aman ME and Smead WL. "Complement Depletion Accelerates the Clearance of Immune Complexes from the Circulation of Primates." J Clin Invest. Vol. 74, no. 74. (January 1984.): 1329-1340.

Kraut EH, Grever MR, Balcerzak SP, Malspeis L, Coleman MS, Staubus A and Wilson HE. "Combination of 2-Deoxycoformycin and Vidarabine in Advanced Malignancy: Clinical and Biochemical Observations." Cancer Treat Symp. Vol. 20, no. 2. (March 1984.): 97-103.

Kraut EH and Sagone AL Jr. "A Role for Sulfhydryl Groups in Granulocyte Aggregation." Blood. Vol. 63, no. 63. (January 1984.): 1056-1059.

Neidhart, J, A; Derocher, D; Grever, M, R; Kraut, EH; Malspeis, L. "Phase I trial of teroxirone.." Cancer treatment reports. Vol. 68, no. 9. (January 1984.): 1115-9.

Grever,M,R; LEIBY,J,M; Kraut,E,H; Wilson,H,E; Neidhart,J,A; WALL,R,L; Balcerzak,S,P. "LOW-DOSE DEOXYCOFORMYCIN IN LYMPHOID MALIGNANCY." JOURNAL OF CLINICAL ONCOLOGY. Vol. 3, no. 9. (January 1985.): 1196-1201.

Kraut EH, Tuomari D, Rojko J and Olsen R. "Effects of Cobra Venom Factor Treatment on Latent Feline Leukemia Virus Infection." J Virol. Vol. 54, no. 54. (January 1985.): 873-875.

Ju, Rong; Kraut, Eric H.; Muller, Mark. "Identification of camptothecin resistance in multiple myeloma and administration of UCN-01 to overcome resistance." Blood. Vol. 98, no. 11 Part 1. (March 1986.): 101a-.

Inamasu, M, S; Oishi, N; Chen, T, T; Kraut, EH; Grozea, P, N; Costanzi, J, J; Bonnet, J D. "Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.." Cancer treatment reports. Vol. 70, no. 4. (January 1986.): 531-2.

Kraut, EH; Bouroncle, B, A; Grever, M R. "Low-dose deoxycoformycin in the treatment of hairy cell leukemia.." Blood. Vol. 68, no. 5. (November 1986.): 1119-22.

Neidhart, J, A; Young, D, C; Kraut, E; Howinstein, B; Metz, E N. "Phase I trial of homoharringtonine administered by prolonged continuous infusion.." Cancer research. Vol. 46, no. 2. (February 1986.): 967-9.

Leiby, J, M; Snider, K, M; Kraut, EH; Metz, E, N; Malspeis, L; Grever, M R. "Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity.." Cancer research. Vol. 47, no. 10. (January 1987.): 2719-22.

Kraut EH, Rojko J, Olsen R and Tuomari D. "Effects of Treatment with Cobra Venom Factor on Experimentally Induced Feline Leukemia." Am J Vet Res. Vol. 48, no. 48. (January 1987.): 1063-1066.

Kraut EH, Leiby JM, Snider Y, Metz EN, Malspeis L and Grever MR. "A Phase II Trial of 9-B-D-Arabinofuranosyl-2-Fluoroadenine-5-Monophosphate in Non-Hodgkin's Lymphoma: Prospective Comparison of Response with Deoxycytidine Kinase Activity.." Cancer Res. no. 47. (January 1987.): 2719-2722.

BOURONCLE,B,A; Grever,M,R; Kraut,E,H. "TREATMENT OF HAIRY-CELL LEUKEMIA - THE OHIO-STATE-UNIVERSITY EXPERIENCE WITH DEOXYCOFORMYCIN." LEUKEMIA. Vol. 1, no. 4. (April 1987.): 350-354.

Kraut EH , Vess J, Schwebel A and Moreland J. "Psychosocial Needs of Cancer Patients: Learning from Patients and Their Spouses." J Psychosoc Oncol. Vol. 20, no. 6(1/2). (November 1988.): 31-52.

Kraut EH. "Lymphadenopathy in a 69 Year Old Woman.." Contemporary Internal Medicine: Clinical Case Studies. Vol. 2, (October 1989.): 157-.

Kraut, EH; Bouroncle, B, A; Grever, M R. "Pentostatin in the treatment of advanced hairy cell leukemia.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Vol. 7, no. 2. (February 1989.): 168-72.

Kraut EH, Leiby JM, Purcell H, DeMaria JJ and Sagone AL. "Pulmonary Embolism as a Result of Hickman Catheter-Induced Thrombosis." Am J Med. Vol. 86, no. 86. (February 1989.): 228-231.

Triozzi, PL; Avery, KA; Grever, MR; Kraut, EH. "Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.." Journal of interferon research. Vol. 10, no. 5. (October 1990.): 535-40.

Kraut EH, Triozzi PL, Avery KA and Grever MR. "Combined Effects of Interferon and 2-Deoxycoformycin on 2, 5-Oligoadenytlate Synthetase and Adenosine Deaminase in Hairy Cell and Chronic Lymphocytic Leukemia Cells.." J Interferon Res. Vol. 20, no. 10. (April 1990.): 535-540.

Grever, M; Leiby, J; Kraut, E; Metz, E; Neidhart, J; Balcerzak, S; Malspeis, L. "A comprehensive phase I and II clinical investigation of fludarabine phosphate.." Seminars in oncology. Vol. 17, no. 5 Suppl 8. (October 1990.): 39-48.

Kraut EH, Neff JC, Bouroncle BA, Gochnour D and Grever MR. "Immunosuppressive Effects of Pentostatin." J Clin Oncol. Vol. 8, no. 8. (May 1990.): 848-855.

Kraut EH, Crowley JJ, Grever MR, Keppen MD, Bonnet JD, Hynes HE and Salmon SE. "Phase II Study of Fludarabine Phosphate in Multiple Myeloma: A Southwest Oncology Group Study." Invest New Drugs. Vol. 8, no. 8. (May 1990.): 199-200.

Kraut EH, Grever MR, Crowley J, Salmon S, McGee R, Buys SS and Rivkin SE. "Phase II Investigation of Pentostatin in Multiple Myeloma: A Southwest Oncology Group Study.." J Natl Cancer Inst. Vol. 82, no. 82. (November 1990.): 1778-1779.

Kraut EH, Fleming T, Segal M, Neidhart JA, Behrens BC, MacDonald J. "Phase II study of pibenziomol in pancreatic cancer. A Southwest Oncology Group study.." Invest New Drugs. Vol. 9, no. 1. (February 1991.): 95-6.

Kraut EH, Chun HG. "Fludarabine phosphate in refractory hairy cell leukemia." Am J Hematol. Vol. 37, no. 1. (May 1991.): 59-60.

Grever, Michael; Brager, Paul; Kraut, Eric; Metz, Earl. "A phase Ii investigation of pentostatin in metastatic malignant melanoma." Investigational New Drugs. Vol. 10, no. 4. (November 1992.): 345-346.

Kraut EH, Husney R and Sagone AL Jr. "The Glucose Metabolism of Hairy Cells.." Leukemia. Vol. 6, no. 6. (January 1992.): 834-838.

Kraut EH, Bendetti J, Balcerzak SP and Doroshow JH. "Phase II trial of merbarone in soft tissue sarcoma: A Southwest Oncology Group Study.." Invest New Drugs. Vol. 10, no. 4. (November 1992.): 347-9.

Kraut EH, Fleming T, Macdonald JS, Spiridonidis CH, Bradof JE, Baker LH. "Phase II trial of merbarone in Pancreatic carcinoma. A Southwest Oncology Group study.." Am J Clin Oncol. Vol. 16, no. 4. (August 1993.): 147-149.

Supko, Jeffrey G.; Balcerzak, S. P.; Kraut, Eric H.. "Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors." Cancer Research. Vol. 53, no. 20. (October 1993.): 4843-4849.

Kraut, Eric H.; Grever, Michael R.; Bouroncle, Bertha A.. "Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin." Blood. Vol. 84, no. 12. (December 1994.): 4061-4063.

Kraut EH. "Cross-resistance to purine analogs in hairy cell leukemia.." Ann Intern Med. Vol. 120, no. 3. (February 1994.): 247-8.

Kraut, EH. "Cross-resistance to purine analogs in hairy cell leukemia.." Annals of internal medicine. Vol. 120, no. 3. (January 1994.): 247-8.

Kraut EH, Flanigan RC, Wolf M, Saiers J, Smith A and Crawford D. "A Southwest Oncology Group Study of Phase II Evaluation of Merbarone in Renal Cell Carcinoma.." Invest New Drugs. Vol. 12, no. 2. (January 1994.): 147-149.

Subramanian, D; Kraut, E; Staubus, A; Young, D, C; Muller, M T. "Analysis of topoisomerase I/DNA complexes in patients administered topotecan.." Cancer research. Vol. 55, no. 10. (January 1995.): 2097-103.

Subramanian,D; Kraut,E; STAUBUS,A; Young,D,C; Muller,M,T. "ANALYSIS OF TOPOISOMERASE I/DNA COMPLEXES IN PATIENTS ADMINISTERED TOPOTECAN." CANCER RESEARCH. Vol. 55, no. 10. (May 1995.): 2097-2103.

Subramanian,D; Kraut,E; STAUBUS,A; Young,D,C; Muller,M,T. "ANALYSIS OF TOPOISOMERASE I/DNA COMPLEXES IN PATIENTS ADMINISTERED TOPOTECAN." CANCER RESEARCH. Vol. 55, no. 10. (May 1995.): 2097-2103.

Grever, M, R; Leiby, J, M; Kraut, EH; Wilson, H, E; Neidhart, J, A; Wall, R, L; Balcerzak, S P. "Low-dose deoxycoformycin in lymphoid malignancy.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Vol. 3, no. 9. (May 1995.): 1196-201.

Slavik,M; Liu,P,Y; Kraut,E,H; Natale,R,B; Flaherty,L,E; Sondak,V,K. "EVALUATION OF MERBARONE (NSC-336628) IN DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY." INVESTIGATIONAL NEW DRUGS. Vol. 13, no. 2. (January 1995.): 143-147.

Slavik, M; Liu, PY; Kraut, EH; Natale, RB; Flaherty, LE; Sondak, V K. "Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study.." Investigational new drugs. Vol. 13, no. 2. (January 1995.): 143-7.

Golomb, H, M; Kraut, EH; Oviatt, D, L; Prendergast, E, J; Stein, R, S; Sweet, D L. "Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia.." American journal of hematology. Vol. 14, no. 1. (September 1996.): 49-56.

Apseloff, G; Fluids, G; LaBoy-Goral, L; Kraut, E; Vincent, J. "Severe neutropenia caused by recommended prophylactic doses of rifabutin.." Lancet. Vol. 348, no. 9028. (January 1996.): 685-.

Kraut EH, Walker MJ, Staubus A, Gochnour D, Balcerzak SP. "Phase II Trial of Topotecan in Malignant Melanoma.." Cancer Invest. Vol. 15, no. 4. (January 1997.): 318-20.

Kraut EH, Koch CA, Archer TP. "Myocardial ischemia in a patient with chronic refractory idiopathic thrombocytopenia purpura.." Arch Intern Med. Vol. 157, no. 22. (December 1997.): 2668-.

Kraut, Eric H.; Walker, Michael J.; Staubus, Al; Gochnour, Diane; Balcerzak, Stanley P.. "Phase II trial of topotecan in malignant melanoma." Cancer Investigation. Vol. 15, no. 4. (January 1997.): 318-320.

Koch, C, A; Archer, T, P; Kraut, E H. "Myocardial ischemia in a patient with chronic refractory idiopathic thrombocytopenic purpura.." Archives of internal medicine. Vol. 157, no. 22. (January 1997.): 2668-.

Kraut, Eric H.; Ju, Rong; Muller, Mark. "The use of topoisomerase I inhibitors in multiple myeloma." Seminars in Hematology. Vol. 35, no. 3 SUPPL. 4. (January 1998.): 32-38.

Kraut, Eric H.; Crowley, John J.; Wade, James L.; Laufman, Leslie R.; Alsina, Melissa; Taylor, Sarah A.; Salmon, Sydney E.. "Evaluation of topotecan in resistant and relapsing multiple myeloma: A Southwest Oncology Group Study." Journal of Clinical Oncology. Vol. 16, no. 2. (January 1998.): 589-592.

Brandt, J, T; Britton, A; Kraut, E. "A spontaneous factor V inhibitor with unexpected laboratory features.." Archives of pathology & laboratory medicine. Vol. 110, no. 3. (February 1998.): 224-7.

Kraut EH, Crowley JJ, Wade JL, Laufman LR, Alsina M, Taylor SA, Salmon SE. "Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group Study.." J Clin Oncol. Vol. 16, no. 2. (February 1998.): 589-92.

Eric Kraut, Jing Liu, Jonathan Bender, Rebecca Brooks, Stanley Balcerzak, Michael Grever, Harriet Stanley, Steven D'Ambrosio, Ruth Gibson-D'Ambrosio, Kenneth K. Chan. "Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.." Cancer Chemotherapy and Pharmacology. Vol. 49, no. 5. (February 1998.): 367-374.

Camisa C, Kraut EH, and Jayanthi-Zvara B. "Psoriatic Sera Decrease Responses of Stimulated Granulocytes from Normal and Psoriatic Subject." J Invest Dermatol. Vol. 16, no. 82. (February 1998.): 318-321.

Kraut,E,J; ANDERSON,J,T; Safwat,A; Barbosa,R; Wolfe,B,M. "Impairment of cardiac performance by laparoscopy in patients receiving positive end-expiratory pressure." ARCHIVES OF SURGERY. Vol. 134, no. 1. (January 1999.): 76-80.

Bouroncle BA, Grever MR and Kraut EH. "Treatment of Hairy Cell Leukemia: The OSU Experience with Deoxycoformycin.." Leukemia. Vol. 23, no. 1. (September 1999.): 350-354.

Kraut EH, Karanes C, Kopecky KJ, Head DR, Grever MR, Hynes HE, Vial RH, Lichtin A, Nand S, Samlowski WE, Appelbaum FR. "A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia. A Southwest Oncology Group Study.." Leuk Res. Vol. 23, no. 9. (September 1999.): 787-94.

Kraut EH, Ju Rong, Muller Mark. "The Use of Topoisomerase I Inhibitors in Multiple Myeloma.." Semin Hematology. Vol. 35, no. 3 Suppl 4. (July 1999.): 32-8.

Liu, Jing; Kraut, Eric; Bender, Jonathan; Brooks, Rebecca; Balcerzak, Stanley; Stanley, Harriot; D'Ambrosio, Steven; Chan, Kenneth K.. "Total oxaliplatin (NSC-266046) levels in plasma and ultrafiltrate in rats and in patients in combination with paclitaxel as measured by inductively coupled plasma mass spectometry." Proceedings of the American Association for Cancer Research Annual Meeting. no. 41. (January 2000.): 702-.

Kraut, Eric H.; Balcerzak, Stanley P.; Young, Donn; O'Rourke, Mark A.; Petrus, John J.; Kuebler, J. Philip; Mayernik, David G.. "A phase II study of 9-aminocamptothecin in patients with refractory breast cancer." Cancer Investigation. Vol. 18, no. 1. (January 2000.): 28-31.

Kraut, Eric H.. "Phase II trials of pentostatin (Nipent) in hairy cell leukemia." Seminars in Oncology. Vol. 27, no. 2 Suppl. 5. (January 2000.): 27-31.

Kraut EH, Balcerzak SP, Young D, O’Rourke MA, Petrus JJ, Keubler JP, Mayernik, DG. "A phase II study of 9-aminocamptothecin in patients with refractory breast cancer.." Cancer Invest. Vol. 18, no. 1. (January 2000.): 28-31.

Kraut EH, Chauncey TR, Rankin C, Anderson JE, Chen I, Kopecky KJ, Godwin JE, Kalaycio ME, Moore DF, Shurafa MS, Petersdorf SH, Leith CP, Head DR, Luthardt FW, Willman CL, Appelbaum FR. "A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: A Southwest Oncology Group study 9617.." Leuk Res. Vol. 14, no. 11A. (November 2000.): 53-61.

Kraut EH, Applebaum FR, Baer MR., Carabasi MH, Coutre SE, Erba HP, Estey E, Glenn MJ, Maslak P, Millenson M., Miller CB, Saba HI, Stone R, Tallman MS. "NCCN Practice Guidelines for Acute Myelogenous Leukemia.." Oncology (Huntingt).. Vol. 14, no. 11A. (November 2000.): 53-61.

Marcucci, Guido; Byrd, John C.; Cataland, Spero R.; Fisher, Diane B.; Lucas, David; Chan, Kenneth K.; Klisovic, Marko; Young, Donn C.; Didier, Lisa A.; Balcerzak, Stanley P.; Frankel, Stanley R.; Kraut, Eric H.; Bloomfield, Clara D.; Grever, Michael R.; Caligiuri, Michael A.. "Clinical and biological activity of GenasenseTM (G3139, Genta, Inc.) (GS), a bcl-2 antisense, in refractory (REF) or relapsed (REL) acute leukemia (AL): A phase I study." Blood. Vol. 98, no. 11 Part 2. (July 2001.): 216b-.

Kuebler, J, P; King, G, W; Triozzi, P; Moore, T; Kraut, EH. "Phase II study of pyrazoloacridine in metastatic renal cell carcinoma.." Investigational new drugs. Vol. 19, no. 4. (June 2001.): 327-8.

Kraut EH, Kuebler JP, King G, Triozzi P and Moore T. "Phase II Study of Pyrazoloacridine in Metastatic Renal Cell Carcinoma.." Invest New Drugs. Vol. 19, no. 4. (August 2001.): 327-8.

Saad, Everardo D.; Kraut, Eric H.; Hoff, Paulo M.; Moore, Dennis F., Jr.; Jones, Donnah; Pazdur, Richard; Abbruzzese, James L.. "Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer." American Journal of Clinical Oncology. Vol. 25, no. 5. (October 2002.): 451-453.

Liu, Jing; Kraut, Eric H.; Balcerzak, Stanley; Grever, Michael; D'Ambrosio, Steven; Chan, Kenneth K.. "Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.." Cancer Chemotherapy and Pharmacology. Vol. 50, no. 6. (December 2002.): 445-453.

Eric Kraut, Jing Liu, Stanley Balcerzak, Michael Grever. "Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.." Cancer Chemotherapy Pharmacology. Vol. 50, no. 6. (December 2002.): 445-53.

Kraut, Eric, H; Balcerzak, Stanley, P; Young, Donn; Davis, Mellar, P; Jacobs, Samuel A. "A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study.." Cancer investigation. Vol. 20, no. 2. (September 2002.): 174-9.

Liu, Jing; Kraut, Eric; Bender, Jonathan; Brooks, Rebecca; Balcerzak, Stanley; Grever, Michael; Stanley, Harriet; D'Ambrosio, Steven; Gibson-D'Ambrosio, Ruth; Chan, Kenneth K.. "Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients." Cancer Chemotherapy and Pharmacology. Vol. 49, no. 5. (May 2002.): 367-374.

Kraut, Eric H.; Balcerzak, Stanley P.; Young, Donn; Davis, Mellar P.; Jacobs, Samuel A.. "A phase II study of topotecan in non-Hodgkin's lymphoma: An Ohio State University Phase II Research Consortium study." Cancer Investigation. Vol. 20, no. 2. (April 2002.): 174-179.

Thomas, Jason P.; Moore, Timothy; Kraut, Eric H.; Balcerzak, Stanley P.; Galloway, Sharon; Vandre, Dale D.. "A phase II study of CI-980 in previously untreated extensive small cell lung cancer: An Ohio State University Phase II Research Consortium study." Cancer Investigation. Vol. 20, no. 2. (May 2002.): 192-198.

Lee,S,L; Anderson,J,T; Kraut,E,J; Wisner,D,H; Wolfe,B,M. "A simplified approach to the diagnosis of elevated intra-abdominal pressure." JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. Vol. 52, no. 6. (June 2002.): 1169-1172.

Kraut EH, Balcerzak SP, Young D, Davis MP, Jacobs SA. "A Phase II Study of Topotecan inNon-Hodgkin’s Lymphoma: A Phase II Research.." Consortium Study Cancer Invest. Vol. 20, no. 2. (April 2002.): 174-9.

Kraut EH, Whitehead RP, Unger JM, Flaherty LE, Mill GM, Klein CE, Chapman RA, Doolittle GC, Hammond N, Sondak VK. "A phase II trial of pyrazine diazohydroxice in patients with dissemniated malignant melanoma and no prior chemotherapy- A Southwest Onocology Group Study.." Invest New Drugs. Vol. 3, no. 20. (August 2002.): 105-111.

Kraut EH, Saad ED, Hoff PM, Moore DF Jr, Jones D, Pazdur R, Abbruzzese JL. "Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer.." Am J Clin Oncol. Vol. 25, no. 5. (October 2002.): 451-3.

Kraut E, Nadella P, Shapiro C, Otterson, GA, Hauger M, Erdal S, Clinton S, Shah M, Stanek M, Monk P, Villalona-Calero M. "M Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies.." J. Clin. Vol. 25, no. 5. (October 2002.): 451-3.

Whitehead, Robert P.; Unger, Joseph M.; Flaherty, Lawrence E.; Kraut, Eric H.; Mills, Glenn M.; Klein, Catherine E.; Chapman, Robert A.; Doolittle, Gary C.; Hammond, Neel; Sondak, Vernon K.. "A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy: Southwest Oncology Group study." Investigational New Drugs. Vol. 20, no. 1. (February 2002.): 105-111.

Kraut EH, Thomas JP, Moore T, Balcerzak SP, Galloway S, Vandre DD. "A Phase II Study of CI-980 in Previously Untreated Extensive Stage Small Cell Lung Cancer: An Ohio State University Phase II Consortium." Cancer Invest. Vol. 20, no. 2. (November 2002.): 192-8.

Nadella, Padma; Shapiro, Charles; Otterson, Gregory, A; Hauger, Marsha; Erdal, Selnur; Kraut, Eric; Clinton, Steven; Shah, Manisha; Stanek, Mike; Monk, Paul; Villalona-Calero, Miguel A. "Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Vol. 20, no. 11. (June 2002.): 2616-23.

Kraut EH, Marcucci G, Byrd JC, Dai G, Klisovic MI, Kourlas PJ, Young DC, Cataland SR, Fisher DB, Lucas D, Chan KK, Porcu P, Lin ZP, Farag SF, Frankel SR, Zwiebel JA, Balcerzak SP, Bloomfield CD, Grever MR, Caligiuri MA. "Phase I and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed leukemia.." Blood. Vol. 101, no. 2. (January 2003.): 425-32.

Grever, Michael, R Doan, Charles, A; Kraut, Eric H. "Pentostatin in the treatment of hairy-cell leukemia.." Best practice & research. Clinical haematology. Vol. 16, no. 1. (January 2003.): 91-9.

Saxena, Kapil; Gross, Thomas; Zhou, Bi; Kraut, Eric; Shapiro, Amy D.; Hord, Jeffrey; Ruymann, Frederick; Yu, Chack Y.. "Immunogenetics of hemophilia inhibitors: A multicenter Study.." Blood. Vol. 102, no. 11. (January 2003.): 800a-.

Marcucci, Guido; Byrd, John C.; Dai, Guowei; Klisovic, Marko I.; Kourlas, Peter J.; Young, Donn C.; Cataland, Spero R.; Fisher, Diane B.; Lucas, David; Chan, Kenneth K.; Porcu, Pierluigi; Lin, Zhong-Pin; Farag, Sherif F.; Frankel, Stanley R.; Zwiebel, James A.; Kraut, Eric H.; Balcerzak, Stanley P.; Bloomfield, Clara D.; Grever, Michael R.; Caligiuri, Michael A.. "Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.." Blood. Vol. 101, no. 2. (January 2003.): 425-432.

Kraut, Eric H. "Clinical manifestations and infectious complications of hairy-cell leukaemia.." Best Practice & Research. Clinical Haematology. Vol. 16, no. 1. (March 2003.): 33-40.

Kraut E, Hobdy EM, Masters G, Blum K, McKeon A, Byrd B, Davies M, Beaulieu N, Murren JR. "A Phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer.." Cancer Biol Ther. Vol. 3, no. 1. (January 2004.): 89-93.

Hobdy, Erole, M; Kraut, Eric; Masters, Gregory; Blum, Kathleen; McKeon, Anne; Byrd, Boyd; Davies, Marianne; Beaulieu, Nancy; Murren, John R. "A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer.." Cancer biology & therapy. Vol. 3, no. 1. (January 2004.): 89-93.

Philip Kuebler, J; Moore, Timothy; Pritchard, James; Kraut, Eric. "Phase II study of CI-958 in patients with hormone refractory prostate carcinoma.." Investigational new drugs. Vol. 22, no. 2. (January 2004.): 181-4.

Kraut E, Philip KJ, Moore T, Pritchard J. "Phase II study of CI-958 in patients with hormone refractory prostate carcinoma.." Invest New Drugs. Vol. 22, no. 2. (April 2004.): 182-4.

Kraut, Eric, H; Young, Donn; Farag, Sherif; James, Arthur, G; Solove, Richard J. "Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma.." Leukemia research. Vol. 29, no. 10. (October 2005.): 1233-4.

Kraut EH, Young D, Farag S,. "Phase II Study of topotecan and cyclosphsphamide in patients with relapsed and refractory multiple myeloma." Leuk Res. Vol. 29, no. 10. (October 2005.): 1233-4.

Kraut EH, Mauer AM, Krauss SA, Ansari RH, Kasza K, Szeto L, Vokes EE. "Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus." Annals of Oncology. (August 2005.): -.

Eric EH, Rogers GM 3rd, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Demetri GD, Djulbegovic B, Gars JL, Gore M, Lin WC, Milleson m, Mock V, Reinke D, Rosenthal J, Sabbatini P. "Cancer- and treatment-related anemia." J Natl Compr Canc Netw. Vol. 3, no. 6. (November 2005.): 772-.

Mauer, A, M; Kraut, EH; Krauss, S, A; Ansari, R, H; Kasza, K; Szeto, L; Vokes, E E. "Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.." Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. Vol. 16, no. 8. (January 2005.): 1320-5.

Raman, Subha, V; Simonetti, Orlando, P; Cataland, Spero, R; Kraut, Eric H. "Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease.." Haematologica. Vol. 91, no. 10. (October 2006.): 1329-35.

Cataland,Spero,R; Kraut,Eric,H; Benson,Don; Ferketich,Amy,K; Horne,April; Jin,Ming; George,James,N; Wu,Haifeng,M. "Improved clinical outcome and ADAMTS13 activity after concurrent cyclosporine and plasma exchange in TTP.." BLOOD. Vol. 108, no. 11. (November 2006.): 314A-314A.

Bekaii-Saab,Tanios,S; Mortazavi,Amir; Hicks,Lee,G; Zalupski,Mark; Pelley,Robert,J; Chan,Kenneth,K; Kraut,Eric,H. "A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC)." INVESTIGATIONAL NEW DRUGS. Vol. 24, no. 4. (July 2006.): 343-346.

Cataland,Spero,R; Jin,Ming; Lin,Shili; Kennedy,Melanie,S; Kraut,Eric,H; George,James,N; Wu,Haifeng,M. "Ciclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity." BRITISH JOURNAL OF HAEMATOLOGY. Vol. 139, no. 3. (November 2007.): 486-493.

Cataland,Spero,R; Jin,Ming; Ferketich,Amy,K; Kennedy,Melanie,S; Kraut,Eric,H; George,James,N; Wu,Haifeng,M. "An evaluation of ciclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura." BRITISH JOURNAL OF HAEMATOLOGY. Vol. 136, no. 1. (January 2007.): 146-149.

Cataland,Spero,R; Kraut,Eric,H; Kennedy,Melanie; Kennedy,Melanie; Jin,Ming; Horne,April; George,James,N; Wu,Haifeng,M. "Abstracts from the American Society for Apheresis 28th Annual Meeting, April 18-21, 2007 Nashville, Tennessee." JOURNAL OF CLINICAL APHERESIS. Vol. 22, no. 2. (April 2007.): 51-87.

Kraut EH, Aledort LM, Arkin S, Stine KC, Wong WY. "Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.." Haemophilia. Vol. 13(5):508, (January 2007.): 517-.

Kerlin BA, Cataland S, Varga E, Kraut E, Wurster M.. "Common Clinical Variables Predict Warfarin Maintenance Dose and Therapeutic Resistance." Throm Thrombolysis. (November 2007.): -.

Bekaii-Saab, Tanios, S; Liu, Jing; Chan, Kenneth, K; Balcerzak, Stanley, P; Ivy, Percy, S; Grever, Michael, R; Kraut, Eric H. "A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel in patients with solid tumors.." Clinical cancer research : an official journal of the American Association for Cancer Research. Vol. 14, no. 11. (June 2008.): 3434-40.

Cataland SR, Jin M, Lin S, Kraut EH, George JN, Wu HM. "Effect of Prophylactic Cyclosporine Therapy on ADAMTS13 Biomarkers in Patients with Idiopathic Thrombotic Thrombocytopenic Purpura." AM J Hematol. Vol. 83, no. 12. (December 2008.): 911-915.

Rogers GM, Becker PS, Bennett CL, Cella D, chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R.. "Cancer- and chemotherapy –induced anemia." J Natl Compre Canc Netw. Vol. 6, (July 2008.): 536-64.

Kraut, Eric, Ballas, Mike. "Bleeding and Bruising: A Diagnostic Work-up." American Family Physician. Vol. 77, (April 2008.): 1117-1124.

Hamadani, Mehdi; Kraut, Eric H. "Review: isolated skeletal involvement in hairy cell leukemia.." Clinical advances in hematology & oncology : H&O. Vol. 6, no. 4. (April 2008.): 294-296.

Hofmeister, C, C; Jansak, B; Denlinger, N; Kraut, EH; Benson, D, M; Farag, S S. "Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma.." Leukemia research. Vol. 32, no. 8. (January 2008.): 1295-8.

Brooke S. Crawford, Robert M. McNulty, Eric H. Kraut, Robert C. Turowski. "Extended Use of Intravenous Bisphosphonate Therapy for the Prevention of Skeletal Complications in Patients with Cancer." Cancer Investigation. Vol. 27, no. 10. (December 2009.): 984-8.

Ntukidem, Nse; Arce lara, Carlos; Otterson, Gregory; Kraut, Eric; Cataland, Spero; Bekaii-Saab, Tanios. "Capped-Dose Mitomycin C (MMC): A Pooled Safety Analysis from Three Prospective Clinical Trials." Cancer Chemotherapy and Pharmacology. Vol. 65, (May 2009.): 319-324.

Cataland,Spero,R; Yang,Shang-Bin; Witkoff,Leslie; Kraut,Eric,H; Lin,Shili; George,James,N; Wu,Haifeng,M. "Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura." EUROPEAN JOURNAL OF HAEMATOLOGY. Vol. 83, no. 6. (December 2009.): 559-564.

Farag,Sherif,S; Zhang,Shuhong; Jansak,Buffy,S; Wang,Xiaojing; Kraut,Eric; Chan,Kenneth; Dancey,Janet,E; Grever,Michael,R. "Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma." LEUKEMIA RESEARCH. Vol. 33, no. 11. (November 2009.): 1475-1480.

Lin TS, Blum KA, fischer DB, Mitchell SM, Ruppert AS, Porcu P, Kraut EH, Baiocchi RA, Moran ME, Johnson AJ, Schaaf LJ, Grever MR, Byrd JC. "Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders." J Clin Oncol. Vol. 28, no. 3. (January 2010.): 418-423.

Serna DS, Bekaii-Saab T, Kraut EH. "A Phase I Study of Topotecan and Gemcitabine in Advanced Solid Tumors." Invest New Drugs. Vol. 29, (June 2010.): 1390-1394.

Kraut EH, Rhoades C, Zhang Y, Cheng H, Aimiumi J, Chen P, Lang J, Young DC, Agarwal A, Dancey J, Chan KK, Grever MR.. "Phase I and Pharmacokinetic Study of Erlotinib (OSI-774) in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck (SSCHN)." Cancer Chemother Pharmacol. (May 2010.): -.

Hofmeister,Craig,C; Yang,Xiaoxia; Pichiorri,Flavia; Chen,Ping; Rozewski,Darlene,M; Johnson,Amy,J; Lee,Seungsoo; Liu,Zhongfa; Garr,Celia,L; Hade,Erinn,M; Ji,Jia; Schaaf,Larry,J; Benson,Don,M; Kraut,Eric,H; Hicks,William,J; Chan,Kenneth,K; Chen,Ching-Shih; Farag,Sherif,S; Grever,Michael,R; Byrd,John,C; Phelps,Mitch,A. "Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide-CCI-779 Interaction via P-Glycoprotein." JOURNAL OF CLINICAL ONCOLOGY. Vol. 29, no. 25. (September 2011.): 3427-3434.

Ramaswamy B; Mrozek E; Kuebler JP; Bekaii-Saab T; Kraut EH. "Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.." Investigational New Drugs. Vol. 29, no. 2. (April 2011.): 347-.

Kraut E. "Infectious complications in hairy cell leukemia.." Leukemia & Lymphoma. Vol. 52 Suppl 2, (June 2011.): 50-.

Kraut EH; Rhoades C; Zhang Y; Cheng H; Aimiumu J; Chen P; Lang J; Young DC; Agrawal A; Dancey J; Chan KK; Grever MR. "Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN).." Cancer Chemotherapy And Pharmacology. Vol. 67, no. 3. (March 2011.): 579-.

Chacko P, Kraut EH, Zweier J, Hitchcock C, Raman SV.. "Myocardial Infarction in Sickle Cell Disease: Use of Translational Imaging to Diagnos an Under-Recognized Problem.." J Cardiovasc Transl Res.. Vol. ., (November 2012.): .-.

Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B, Gilreath JA, Kraut EH, Matulonis UA, Millenson MM, Reinke D, Rosentahl J, Schwartz RN, Soff G, Stein Rs, VLahovic G, Weir AB 3rd.. "Cancer – and chemotherapy-induced anemia.." J Natl Compr Canc Netw.. Vol. 10, no. 5. (May 2012.): 628-53.

Jones,Jeffrey,A; Kraut,Eric,H; Deam,Deidre; Byrd,John,C; Grever,Michael,R. "Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia." LEUKEMIA & LYMPHOMA. Vol. 53, no. 3. (March 2012.): 490-491.

Rachel M. Layman, Amy S. Ruppert, Melinda Lynn, Ewa Mrozek, Bhuvaneswari Ramaswamy, Maryam B. Lustberg, Robert Wesolowski, Susan Ottman, Sarah Carothers, Anissa Bingman, Raquel Reinbolt, Eric H. Kraut, Charles L. Shapiro.. "Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.." Springer-Verlag Berlin Heidelberg.. Vol. 71, no. 5. (February 2013.): 1183-90.

Martin LK, Bekaii-Saab T, Serna D, Monk P, Clinton SK, Grever MR, Kraut EH.. "A Phase I Dose Escalation and Pharmacodynamic Study of SU5416 (Semaxanib) .." Onkologie. Vol. 11, no. 36. (October 2013.): 657-60.

Hofmeister CC, Poi M, Bowers MA, Zhao W, Phelps MA, Benson DM, Kraut EH, Farag S, Efebera YA, Sexton J, Lin TS, Grever M, Byrd JC.. "A Phase I Trial of Flavopiridol in Relapsed Multiple Myeloma.." Cancer Chemother Pharmacol.. -.

 

Reference Works

January 1977 EH Kraut, Leiby JM, Metz EN, Malspeis L and Grever MR."A Prospective Comparison of Deoxycytidine Kinase Activity with Response to 2-Fluoro-Ara-Amp in Patients with Non-Hodgkin's Lymphoma" . : 66(1):215A
January 1977 EH Kraut, Dunlap JE, Stevenson TD and King GW."Immune Function in Successfully Treated Acute Leukemia Patients" . : Clin Res, 25:578A
January 1978 EH Kraut, Metz EN and Sagone AL Jr."In Vitro Effects of Ascorbic Acid (AA) on the Chemiluminescence of granulocytes (PMN's)" . : 25:578
January 1978 EH Kraut and Sagone AL Jr."The Alternative Pathway of Complement in Multiple Myeloma" . : 19:270
January 1981 Segal ML, Fertel RH, EH Kraut, Sagone AL Jr."The Role of Reactive Oxygen Species in Thromboxane B2 Generation by Human Polymorphonuclear Leukocytes" .
January 1981 Kaiki JH, Stephens R, Leite CF EH Kraut, Fletcher W."Phase II Evaluation of Gallium Nitrate (NSC152000) in Soft Tissue and Bone Sarcomas." . : 22:525
January 1981 EH Kraut and Sagone AL Jr."The Effect of Oxygen Radical Scavengers on Polymorphonuclear Leukocyte Aggregation" . : 29:338A
January 1981 EH Kraut and Sagone AL Jr."A Role for Sulfhydryl Groups in Polymorphonuclear Leukocyte Aggregation" . : 29:338
January 1982 Hebert IA, Waxman FJ, Birmingham DJ, Cornacoff JB, Van Aman MA, Smead WL, EH Kraut.."Complement (C) Depletion Accelerates the Clearance of Immune Complexes (IC) from the Circulation of Primates" .
January 1983 EH Kraut, Grever MR, Neidhart JA and Malspeis L."2-Fluoro ARA-AMP: A Phase I Clinical Investigation" Brussels, Belgium.
January 1983 EH Kraut, Grever MR, Wilson HE, Neidhart JA and Balcerzak SP."Deoxycoformycin (dCF) in the Treatment of Refractory Chronic Lymphocytic Leukemia (CLL)" Brussels.
January 1984 EH Kraut, Grever MR, Leiby JM, Neidhart JA, Malspeis L and Balcerzak SP."A Phase I Investigation of 2-Fluoro-ARA-AMP in Refractory Leukemia" . : 64(1):165A
January 1984 EH Kraut, Leiby J, Grever M, Metz E and Malspeis L."FAMP Therapy in Lymphoma" . : 64(1):182A
January 1984 E Kraut, Ehrlichman C, Robert F, Velez-Garcia E, Bender J and Grillo-Lopez A."A Phase II Trial of Diaziquone (AZQ) in Patients with Colon Cancer" . : 3:C527
January 1985 Malspeis L, Balcerzak SP and Grever MR."Phase I Clinical Trial of Pibenzimol" . : 4:C143
January 1985 EH Kraut, Wenger GD, O'Dorisio MS."Characterization of cAMP-Dependent Protein Kinases During Differentiation of Normal and Leukemic Monocytes and U937 Cells" . : 33(2):357A
January 1985 EH Kraut, Neidhart JA, Metz EN and Howenstein B."Phase I Study of Homoharringtonine (HH) Administered by Prolonged Continuous Infusion" . : 4:C188
January 1985 EH Kraut, Leiby JM, Metz EN, Neidhart JA, Malspeis L and Grever MR."Fludarabine Phosphate in Relapsed Non-Hodgkin's Lymphoma" . : 33:891A
January 1985 EH Kraut, Grever MR, Gochnour DC, Neidhart JA."A Phase I Clinical Investigation of Acodazole" . : 26:702
January 1985 EH Kraut, Bouroncle BA and Grever MR."Treatment of Hairy Cell Leukemia with Low Dose 2-Deoxycoformycin" Chicago, Illinois.
January 1986 Grever MR, Leiby JM, Wilson HE, EH Kraut, Wall RW, Bouroncle BA, Metz EN, Rinehart JJ and Balcerzak SP."Deoxycoformycin in Chronic Leukemia" Sydney, Australia.
January 1986 EH Kraut, O'Dorisio TM, Page JG and Grieshaber CK."Evaluation of the Pancreatic Toxicity of Pibenzimol (NSC 32292 1) in Dogs" Los Angeles, California. : 27:420
January 1986 EH Kraut, Neff JC and Grever MR."Immune Function in Hairy Cell Leukemia Patients in Complete Remission after 2-Deoxycoformycin" . : 68(1):225A
January 1986 EH Kraut, Grever MR, Gochnour DC, Neidhart JA, Balcerzak SP and Malspeis L."A Phase I Clinical Investigation of Acodazole" . : 5:53
January 1986 EH Kraut, Grever MR, and Leiby JM."Correlation of Biochemical Parameters to Response with Deoxycoformycin (dCF) in Chronic Leukemia" . : 27:195
January 1987 Grever MR, McGee RA, EH Kraut, Salmon SE and Athens JW."Deoxycoformycin in Refractory Myeloma" . : 70(1):246A
January 1987 EH Kraut, Bouroncle BA and Grever MR."Low Dose 2-Deoxycoformycin in the Treatment of Advanced Hairy Cell Leukemia" . : 70(1):232A
January 1987 Theil KS, Bouroncle BA and Grever MR, EH Kraut.."Bone Marrow Changes in Hairy Cell Leukemia Treated with Low-Dose Deoxycoformycin" . : 70(1):239A
January 1987 Malspeis L, Staubus AE, Supko JG, Grever MR, EH Kraut.."Pharmacokinetics and Metabolism of Merbarone NSC 336628) in Patients" . : 28:906
January 1988 Grever MR, EH Kraut, Supko JG, Trewyn RW, Staubus AE and Malspeis L."(NSC 336628) Enhances the Urinary Excretion of Uric Acid of Cancer Patients" . : 29:752
January 1988 EH Kraut, Malspeis L, Balcerzak SP and Grever MR."Evaluation of Pibenzimol (NSC 322921) in Refractory Solid Malignancies" . : 7:237
January 1988 EH Kraut, Grever MR, Staubus AE and Malspeis L."Phase I Clinical Trial of Merbarone (NSC 336628)" .
January 1988 EH Kraut, Grever MR, Leiby JM, Balcerzak SP, Staubus AE and Malspeis L."A Phase I Investigation of Flavone Acetic Acid (NSC 347512)" . : 7:236
January 1988 EH Kraut, Grever MR and Bouroncle BA."Deoxycoformycin (Pentostatin) in the Treatment of Hairy Cell Leukemia" Paris, France (Sponsored by the Pasteur Institute.).
January 1988 Leiby JM, Malspeis L, Staubus AE, Kraut EH, Grever MR."Fazarabine (NSC 281272) is Myelosuppressive at the Initial Dose Level in a Phase I Study" . : 7:235
January 1988 Leiby JM, Malspeis L, Staubus AE, EH Kraut, Grever MR."Amonafide (NSC 308847): A Clinical Phase I Study of Two Schedules of Administration" . : 29:1103
January 1988 JG, Grever MR, Balcerzak SP, EH Kraut, Staubus AE and Malspeis L."Spectral Characterization and Quantitation of the Principal Metabolites of Merbarone (NSC 336628) in the Urine of Patients" . : 29:751
January 1989 EH Kraut, Grever MR and Salmon S."Phase II Trial of Fludarabine Phosphate in Multiple Myeloma" . : 30:1052
January 1990 Grever MR, Brager P, EH Kraut, Metz E."Phase II Trial of Deoxycoformycin in Malignant Melanoma" . : 31:A1181
January 1990 EH Kraut, Neidhart J and MacDonald J."Phase II Trial of Pibenzimol in Advanced Pancreatic Carcinoma: A Southwest Oncology Group Study" . : 9:A504
January 1990 EH Kraut, Neff J, Gochnour D and Grever MR."Immunosuppressive Effects of Pentostatin" Laquana Beach, California.
January 1990 EH Kraut, MR Grever, BA Bouroncle."Long Term Followup of Hairy Cell Leukemia Patients Treated with 2-Deoxycoformycin" Hamburg, Germany.
January 1990 EH Kraut, Bouroncle BA, and Nelson DL."Usefulness of Soluble IL-2 Receptor as a Marker of Disease Activity in Hairy Cell Leukemia" . : 9:A504
January 1990 Wissel M, Hazy L, Williams M, EH Kraut, Blazina J."Platelet Transfusion Responses in a Leukemia Patient with Anti-PLA1" .
January 1990 Staubus AE, Malspeis L, Baleerzak SP, Leiby JM, Kraut ER, Grever MR."Clinical Pharmacokinetics of Fazarabine (NSC 281272)" . : 31:A1054
January 1990 Schisler M, EH Kraut, Muller M."Variability of Topoisomerase I Levels in Leukemia Patients: A Molecular Analysis to Evaluate Clinical Response to Camptothecin" .
January 1991 EH Kraut, Balcerzak SP, Kemmenoe BH and Supko JG."Phase I Clinical Evaluation of Pyrazine Diazohydroxide in Patients with Advanced Solid Tumors" . : 32:A1074
January 1994 Subramanian D, EH Kraut, Staubus A, Muller M."Analysis of Topoisomerase I/DNA Covalent Complexes in Peripheral Blood of Patients Administered Topotecan" .
January 1994 Slavik M, Liu PY, EH Kraut, Natale R, Sondak V."Phase II Evaluation of Merbarone in Disseminated Malignant Melanoma" .
January 1995 EH Kraut, Staubus A, Mayernik D, King G and Balcerzak SP."Phase II Trial of Topotecan in Metastatic Malignant Melanoma" . : 28:204
January 1995 E Kraut, Crowley J, Wade J, Laufman L, Weiss G, Taylor S, Salmon S."Evaluation of Topotecan in Resistant and Relapsing Multiple Myeloma" . : 86(10)(Suppl 1)(#726):185a
January 1996 Koch CA, Archer TP, EH Kraut.."Myocardial Ischemia in a Patient with Chronic refractory Idiopathic Thrombocytopenic Purpura" .
January 1997 EH Kraut, Balcerzak SP, and Young D,."A Phase II Study of Topotecan In Non-Hodgkin’s Lymphoma" . : 15(1):67
January 1998 Chauncey TR, Rankin C, Anderson JE, Godwin JA, Kalaycio M, Moore DF, Petersdorf SH, Shurafa MS, EH Kraut, Head DR, Slovak ML, Willman CL, and Appelbaum FR."A Phase I Dose-Finding Study of Induction Chemotherapy For Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Using Mitoxantrone (M), Etoposide (E), and The MDR Modulator PSC833" .
January 1999 Thomas JP, Moore TD, EH Kraut, Balcerzak SP."A Phase II Study of CI-980 in Previously Untreated Small-Cell Lung Cancer" An Ohio State University Phase II Research Consortium Study.
January 2000 Aguayo A, EH Kraut, Moore D, Hoff P, Wright J, Winn R, Jones D, Pazdur R."Total Oxaliplatin (NSC-266046) Levels in Plasma and Ultrafiltrate in Rats and in Combination with Paclitaxel as Measured by Inductively Coupled Plasma Mass Spectometry" .
January 2001 EH Kraut, Bender J, Liu J, Balcerzak S, Jensen R, Chan K, Dambrosio S, Grever M."Phase I Study of Oxaliplatin (NSC 266046) in Combination with Paclitaxel" .
January 2001 EH Kraut, Bender J, Clinton S, Jensen R, Balcerzak S, Chan K, Mueller C, Vaswani K, Mantil J, Christian B, Grever M."Phase I Study of SU5416 in Combination with CPT-11 and Cisplatin in Patients with Solid Tumors" .
January 2002 Mauer AM, EH Kraut, Rudin CM, Krauss SA, Ansari RH, Hoffman P.C., Saltz L, Vokes, EE."Phase II study of of Oxaliplatin, fluoruracil, and leucovorin in metastatic carcinoma of the esophagus/gastric cardia" .
January 2003 Kuebler JP, Moore T, Pritchard J, EH Kraut.."Phase II Study of CI-958 in patients with Hormone Refractory Prostate Carcinoma" .
January 2003 A.m Mauer, E.H. Kraut, S.A. Krauss, R.H. Ansari, K. Kasza, L. Szeto, E.E. Vokes,."Phase II Trial of Oxaliplatin, Leucovorin, and Fluorouracil in patients with Advanced Carcinoma of the Esophagus" .
January 2004 Lin TS, Fischer B, Moran M, Lucas D, Shank R, EH Kraut, Farag SS, Lucas M, Colevas AD, Grever MR, Byrd JC."Phase I Dose Escalation Study of Flavopiridol in Combination with Fludarabine and Rituximab is Active in Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma" .
January 2004 Ewenstein B, Paul LF, Giangrande PL, Morfini M, Tjonnfjord GE, EH Kraut, Luu H."Evaluation of FEIBA for Prophylaxis in Patients with Inhibitors" Thailand. : 10(s3), 53
January 2004 Eric Kraut, Sylvia Jordan, Leslie Witkoff and Michael Stanek."Control of Bleeding in Patients with Inhibitors to Factor VIII and IX Undergoing" Bangkok, Thailand. : 10:174
January 2004 Negrier C, Tjonnfjord G, EH Kraut, Giangrande PL, Ewenstein Band the FEIBA Study Group."Efficacy of FEIBA in Surgical and Invasive Procedures" . : 10:174
January 2004 Cataland SP, George JN, EH Kraut, Bourgeois T, Ferketich AK, Kennedy MS, Caligiuri MA, Wu HM."Improved Clinical Outcome and ADAMTS13 Activity Following Cyclosporine Therapy in Patients with TTP" . : 104:243a
January 2005 S.S Farag, S. Zhang, M. Miller,M. Buckner, E. Kraut, K Chan, C. Eng, J. Byrd, J.E. Dancey, M.R. Grever."Phase II trial of CCI-779 (Temsirolimus) in patients with relapsed or refractory multiple myeloma: Preliminary results" .
January 2005 Kurt P. Leuenerger, M.D., Spero Cataland, M.D., Ming Jin, M.D., Carol Orr, Guido Marcucci, M.D., Eric H. Kraut, M.D., Jaifeng M. Wu, M.D."Distinguishing Antiphospholipid Antibodies from an Acquired Factor Inhibitor: A Novel Laboratory Approach" . : 106: 2150
January 2005 T.S. Lin, B. Fischer, M.E. Moran, R.S. Shank, E. Kraut, P. Porcu, S.S. Farag, K.A. Blum, A.D. Colevas, M.R. Grever, J.C. Byrd."Flavopiridol, Fludarabine and Rituximab (FFR) is an active regimen in indolent B-cell lymphoproliferative disorders and mantle cell lymphoma (MCL)" . : No. 11, abstract 944, p. 278a
January 2005 Subha V. Raman, Md, MS, Orlando P. Simonetti, PhD, Spero R. Cataland, MD, William J. Hicks, MD, Eric H. Kraut, MD.."Myocardial Ischemia without Coronary Artery Obstruction in Patients with Sickle Cell Disease" Boston, Mass.. : 106(11) 3180
January 2005 Eric H. Kraut, Spero R Cataland, M.D., Leslie Witkoff, R.N., Sylvia Jordan, R.N. and William T Gunning, Ph.D."Evaluation of Qualitative Platelet Disorders in patients with Hemophilia" Boston, Mass.. : 106 (11) 3987
January 2005 EH Kraut, Aledort, LM, Arkin, S, Stine, KC, Wong, W-Y."Surgical Procedures in Patients With Inhibitors To Factor VIII: A Case Series" .
January 2006 Zhiliang Xie, Zhongfa Liu, Lucy Fang, Eric Kraut, Tanios Saab, Xiaohui Wei, Hao Cheng, Duxin Sun, Michael Grever and Kenneth K. Chan."Clinical Pharmcokinetics of the VEGF Kinase Inhibitor SU-5416 in Combination with CPT-11 and Cisplatin in Patients with Solid Tumors using an PII LC-MS/MS Method" .
January 2007 Spero R. Cataland, Min Jin, Shili Lin, Melanie S. Kennedy, Eric H. Kraut, James N. George, Haifeng M. Wu."Prospective Studies with long-term follow-up of Cortitosteroids and Cyclosporine given Individually as adjuncts to plasma exchange in the initial treatment of TTP" Nashville, TN.
January 2007 Bryce Kerlin, Spero Cataland, Elizabeth Varga, Eric Kraut and Mark Wurster."Common Clinical Variables Predict Warfarin Maintenance Dose and Therapeutic Resistance" .
January 2007 Kami Perdue, Spero Cataland, Eric H. Kraut, Carol Blanchong, Sarah O’Brien, and Bryce Kerlin."HTRS TERegistry: Offering A Better Understanding Of ThromboEmbolic Disease" Chicago, IL.
August 2008 TS Lin, B Fischer, Blum KA, P Porcu, EH Kraut, RA Baiocchi, S Broering, MR Grever and JC Byrd."Flavopiridol, Fludarabine and Rituximab (FFR) Is Active Regimen in Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma" .
June 2008 Bekaii-Saab, Kenneth Chan, Stanley Balcerzak, Jing Liu, Percy Ivy, Michael Grever, Eric Kraut.."A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel in patients with solid tumors." . : 3434
May 2013 Rachel M. Layman, Amy S. Ruppert, Melinda Lynn, Ewa Mrozek, Bhuvaneswari Ramaswamy, Maryam B. Lustberg, Robert Wesolowski, Susan Ottman, Sarah Carothers, Anissa Bingman, Raquel Reinbolt, Eric H. Kraut, Charles L. Shapiro.."Cancer Chemother Pharmacol" Berlin. : 1183

Presentations

"Topotecan on Refractory and Relapsing Myeloma." Presented at SWOG, . (April 1995)

"The Role of Topoisomerase I Inhibitors in Multiple Myeloma�." Presented at Topoisomerase I Inhibitor Symposium, San Diego, CA. (December 1997)

"Evaluation of Thrombocytopenia." Columbus, OH. (December 1997)

"Developmental Chemotherapy in multiple myeloma, the search for the magic bullet." Little Rock, AK. (May 1998)

"Pharmacogenomic and pharmacokinetic assessment of liposome encapsulated SN-38 (LE-SN38) in advanced cancer patients." Presented at ASCO Annual Meeting, . (May 2004)

"Control of Bleeding in Patients with Inhibitors to Factor VIII and IX Undergoing Surgical." Presented at Baxter Symposium on Factor VIII Inhibitors, . (April 2004)

"Chemotherapy Principles." Presented at Series Course on Therapeutics, . (February 2004)

"Hematology Introduction." Presented at Med I Lecture, . (December 2005)

"Myeloproliferitive Disease." Presented at ASCO Staff, . (October 2005)

"Sickle Cell Anemia." Presented at James Care for Life, Columbus, OH. (February 2005)

"Sickle Cell Anemia." Presented at Fellow's Conference, . (February 2005)

"Sickle Cell Anemia." Presented at Pain and Pallitive Care Conference, . (June 2005)

"Surgical Procedures in Patients With Inhibitors To Factor VIII." Presented at ISTH Conference, . (August 2005)

"Hemolytic Anemia." Presented at Med I Lecture, . (March 2006)

"Hemolytic Anemia." Presented at Med I Lecture, . (March 2006)

"Sickle Cell Anemia." Presented at Basic Science & Clinical Lecture Series, . (October 2006)

"Hemolytic Anemia." Presented at Basic Science & Clinical Lecture Series, . (October 2006)

"Heme Emergencies Coagulopathies." Presented at Housestaff Lecture, . (August 2006)

"Introduction to Hematology." Presented at Med I Host Defense Lecture, . (March 2007)

"Hemolytic Anemia." Presented at Med I Host Defense Lecture, . (March 2007)

"Coagulation." Presented at Housestaff Lecture, . (June 2007)

"Introduction to Anemia's." Presented at Basic Science & Clinical Lecture Series, . (January 2008)

"Hemophilia." Presented at Basic Science and Clinical Lecture Series, Columbus, OH. (June 2008)

"Hematologic Disorders and the Eye." Presented at Postgraduate Symposium in Opthalmology, . (February 2008)

"HIT/Use of Argatroban/Platelet Function with Reopro." Presented at Cardiology Grand Rounds, Columbus, OH, US|USA. (March 2008)

"Hemolytic Anemia." Presented at Host Defense Lecture, Columbus, OH, US|USA. (March 2008)

"Hematology Emergencies." Presented at Medical Therapeutics Course, Columbus, OH, US|USA. (March 2008)

"Diagnosis and Management of Hemolytic Anemia." Presented at Pharmacy Education Lecture, Columbus, OH. (August 2009)

"Diagnosis and Management of Hemolytic Anemia." Presented at ACPE - Approved Continuing Pharmacy Education, Polaris, OH. (August 2009)

"Clinical Bleeding." Presented at Internal Medicine Resident’s Conference, Columbus, OH. (August 2009)

"Hematologic Malignancies." Presented at NCCN 4th Annual Congress, Columbus, OH. (September 2009)

"Sickle Cell." Presented at Basic Science and Clinical Lecture Series, Columbus, OH. (March 2009)

"Hemoglobinopathies." Presented at Basice Science and Clinical Lecture Series, Columbus, OH. (March 2009)

"Hematalogic Emergencies." Presented at Medical Therapeutics Lecture, Columbus, OH. (March 2009)

"Hemolytic Anemia." Presented at Med I Host Defense Lecture, Columbus, OH. (January 2010)

"Hemoglobinopathies." Presented at Med I Host Defense Lecture, Columbus, OH. (January 2010)

"Hemolytic Anemia/ Sickle Cell Disease." Presented at Basic Science & Clinical Lecture Series, Columbus, OH. (March 2011)

"Benign Hematology." Presented at Fellows Board Review, Columbus, OH. (March 2011)

"Hemophilia in the ED." Presented at Grand Rounds, Zanesville, OH. (April 2011)

"Hematology." Presented at Internal Medicine Resident Report, Columbus, OH. (April 2011)

"Hemolysis." Presented at Host Defense Lecture, Columbus, OH. (January 2011)

"Hemoglobin and Hemoglobinopathies." Presented at Med I Lecture Series, Columbus, OH. (January 2011)

"Disorder of Neutrofil Number and Function." Presented at Basic Science and Clinical Lecture Series, Columbus, OH. (January 2011)

"Bleeding Disorders for the Oral Surgeon." Presented at Maxillofacial Education Lecture, Columbus. (October 2012)

"Complications of Anticoagulant and Thrombolytic Therapy." Presented at American Thoracic Society (ATS), San Francisco. (May 2012)

"Hemochromatosis/Porphyria.." Presented at Basic Science and Clinical Lecture Series., Columbus, OH. (January 2013)

"Sickle Cell Anemia." Presented at Oncology Lab Presentation, Columbus, OH. (February 2013)

"Hypercoagulability and Thrombosis.." Presented at Basic Science and Clinical Lecture Series., Columbus, OH. (January 2013)

"Sickle Cell Anemia." Presented at Basic Science and Clinical Lecture Series, Columbus, OH. (February 2013)

"Hematologic Emergencies." Presented at Medical Therapeutics, Columbus, OH. (April 2013)

"Hemophilia and vonWillebrand's Disease." Presented at Basic Science and Clinical Lecture Series., Columbus, OH. (August 2013)

 

Professional Activities

2006 - present Panel Expert. Net Wellness, Consumer Health Information. Columbus, OH.